Market revenue in 2023 | USD 7.7 million |
Market revenue in 2030 | USD 13.3 million |
Growth rate | 8.1% (CAGR from 2023 to 2030) |
Largest segment | Platelet-rich plasma (prp) |
Fastest growing segment | Other Biologics |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Stem Cells, Platelet-Rich Plasma (PRP), Other Biologics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary orthobiologics market will help companies and investors design strategic landscapes.
Platelet-rich plasma (prp) was the largest segment with a revenue share of 38.96% in 2023. Horizon Databook has segmented the Middle East & Africa veterinary orthobiologics market based on stem cells, platelet-rich plasma (prp), other biologics covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa veterinary orthobiologics market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa veterinary orthobiologics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account